Blair William & CO Acelrx Pharmaceuticals Inc Transaction History

Blair William & CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$0.93 - $1.51 $19,762 - $32,087	-21,250 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$1.03 - $1.7 $412 - $680	400 Added 1.92%	21,250 $29,000
Q1 2021 May 13, 2021	BUY	$1.25 - $2.77 $26,062 - $57,754	20,850 New	20,850 $35,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.